DK1264599T3 - TNF-afledte peptider til anvendelse i behandling af ödem - Google Patents

TNF-afledte peptider til anvendelse i behandling af ödem

Info

Publication number: DK1264599T3
Authority: DK; Denmark
Prior art keywords: tnf; alpha; present; oedema; edema
Prior art date: 1998-08-14

Application number

DK02077256T

Other languages

English (en)

Inventor

Baetselier Patrick De

Rudolf Lucas

Jerome Pugin

Alain Bloc

Lucie Fransen

Original Assignee

Rudolf Lucas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-14

Filing date

1999-08-10

Publication date

2008-02-04

1999-08-10 Application filed by Rudolf Lucas filed Critical Rudolf Lucas

2008-02-04 Application granted granted Critical

2008-02-04 Publication of DK1264599T3 publication Critical patent/DK1264599T3/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
206010030113 Oedema Diseases 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 abstract 1
101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 abstract 1
206010037423 Pulmonary oedema Diseases 0.000 abstract 1
108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
102000057041 human TNF Human genes 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK02077256T 1998-08-14 1999-08-10 TNF-afledte peptider til anvendelse i behandling af ödem DK1264599T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP98870180		1998-08-14
EP98870198		1998-09-18
EP98870222		1998-10-21
PCT/EP1999/005806 WO2000009149A1 (en)	1998-08-14	1999-08-10	Tnf-derived peptides for use in treating oedema

Publications (1)

Publication Number	Publication Date
DK1264599T3 true DK1264599T3 (da)	2008-02-04

Family

ID=27239778

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02077256T DK1264599T3 (da)	1998-08-14	1999-08-10	TNF-afledte peptider til anvendelse i behandling af ödem

Country Status (20)

Country	Link
US (2)	US20030105021A1 (da)
EP (3)	EP1264599B1 (da)
JP (1)	JP4542266B2 (da)
CN (1)	CN1181886C (da)
AT (2)	ATE395072T1 (da)
AU (1)	AU764992B2 (da)
BR (1)	BR9912899A (da)
CA (1)	CA2334941C (da)
CZ (1)	CZ302862B6 (da)
DE (2)	DE69938743D1 (da)
DK (1)	DK1264599T3 (da)
ES (1)	ES2296872T3 (da)
HU (1)	HU227661B1 (da)
IL (2)	IL141064A0 (da)
NZ (1)	NZ509604A (da)
PL (1)	PL203706B1 (da)
PT (1)	PT1264599E (da)
TR (1)	TR200100338T2 (da)
WO (1)	WO2000009149A1 (da)
ZA (1)	ZA200100656B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ302862B6 (cs)	1998-08-14	2011-12-21		Lécivo na lécení otoku
CA2575513C (en)	2004-08-06	2014-09-16	Altana Pharma Ag	Composition comprising a pulmonary surfactant and a tnf-derived peptide
EP2009023A1 (en) *	2007-06-04	2008-12-31	Rentschler Beteiligungs GmbH	Novel peptides and their use for the treatment of edema
AT506151B1 (de)	2007-12-12	2010-01-15	Apeptico Forschung Und Entwick	Fusionsprotein
AT506150B1 (de) *	2007-12-12	2010-01-15	Apeptico Forschung Und Entwick	Zyklisches und cystein-freies peptid
AT507953B1 (de) *	2009-03-05	2011-02-15	Apeptico Forschung & Entwicklung Gmbh	Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität
AT509267A1 (de) *	2010-01-14	2011-07-15	Apeptico Forschung & Entwicklung Gmbh	Organische verbindungen zur regulierung von vektoriellen ionenkanälen
EP2397151B1 (en) *	2010-06-21	2015-04-22	Apeptico Forschung Und Entwicklung Gmbh	Treatment of vascular complications of diabetes
US11161881B2 (en) *	2010-11-18	2021-11-02	Apeptico Forschung Und Entwicklung Gmbh	Composition comprising a peptide and an inhibitor of viral neuraminidase
AT510585B1 (de)	2010-11-18	2012-05-15	Apeptico Forschung & Entwicklung Gmbh	Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
EP2679239A1 (de)	2012-06-28	2014-01-01	Apeptico Forschung und Entwicklung GmbH	Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit
US12004506B2 (en)	2013-04-23	2024-06-11	Apeptico Forschung Und Entwicklung Gmbh	Pharmaceutical composition comprising a cyclic peptide of formula X1-GQRETPEGAEAKPWY-X2 and use for extracorporeal lung treatment
CA2908560C (en) *	2013-04-23	2021-03-09	Apeptico Forschung Und Entwicklung Gmbh	Pharmaceutical composition comprising a cyclic peptide of formula x1-gqretpegaeakpwy-x2 and use for extracorporeal lung treatment
EP3062772B1 (en)	2014-03-18	2018-01-24	APEPTICO Forschung und Entwicklung GmbH	Dry-powder peptide medicament
CN110613838A (zh) *	2018-06-19	2019-12-27	姜石松	增强细胞通透性的多肽及其应用
DK4051307T5 (da)	2020-05-08	2024-07-22	Apeptico Forschung & Entwicklung Gmbh	Peptid til forebyggelse eller behandling af covid-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE384179C (de) *	1921-04-07	1923-10-27	Ludwig Weil Dr	Laufrad fuer Kreiselpumpen und -geblaese
DE3841759A1 (de)	1988-12-12	1990-06-13	Basf Ag	Neue tnf-peptide
CA2155103A1 (en)	1993-02-03	1994-08-18	Rudolph Lucas	Tnf-alpha muteins and a process for preparing them
CZ302862B6 (cs)	1998-08-14	2011-12-21		Lécivo na lécení otoku

1999
- 1999-08-10 CZ CZ20010538A patent/CZ302862B6/cs not_active IP Right Cessation
- 1999-08-10 IL IL14106499A patent/IL141064A0/xx unknown
- 1999-08-10 JP JP2000564651A patent/JP4542266B2/ja not_active Expired - Lifetime
- 1999-08-10 EP EP02077256A patent/EP1264599B1/en not_active Expired - Lifetime
- 1999-08-10 PL PL345997A patent/PL203706B1/pl unknown
- 1999-08-10 WO PCT/EP1999/005806 patent/WO2000009149A1/en not_active Application Discontinuation
- 1999-08-10 EP EP02077274A patent/EP1247531B1/en not_active Expired - Lifetime
- 1999-08-10 AT AT02077274T patent/ATE395072T1/de active
- 1999-08-10 TR TR2001/00338T patent/TR200100338T2/xx unknown
- 1999-08-10 AU AU56209/99A patent/AU764992B2/en not_active Ceased
- 1999-08-10 DK DK02077256T patent/DK1264599T3/da active
- 1999-08-10 CN CNB998096555A patent/CN1181886C/zh not_active Expired - Lifetime
- 1999-08-10 DE DE69938743T patent/DE69938743D1/de not_active Expired - Lifetime
- 1999-08-10 ES ES02077256T patent/ES2296872T3/es not_active Expired - Lifetime
- 1999-08-10 DE DE69937206T patent/DE69937206T2/de not_active Expired - Lifetime
- 1999-08-10 BR BR9912899-3A patent/BR9912899A/pt active Search and Examination
- 1999-08-10 AT AT02077256T patent/ATE374039T1/de active
- 1999-08-10 NZ NZ509604A patent/NZ509604A/en not_active IP Right Cessation
- 1999-08-10 EP EP99942835A patent/EP1105152A1/en not_active Withdrawn
- 1999-08-10 CA CA2334941A patent/CA2334941C/en not_active Expired - Lifetime
- 1999-08-10 PT PT02077256T patent/PT1264599E/pt unknown
- 1999-08-10 HU HU0103117A patent/HU227661B1/hu not_active IP Right Cessation
2001
- 2001-01-23 ZA ZA2001/00656A patent/ZA200100656B/en unknown
- 2001-01-24 IL IL141064A patent/IL141064A/en not_active IP Right Cessation
- 2001-02-09 US US09/779,703 patent/US20030105021A1/en not_active Abandoned
2002
- 2002-06-06 US US10/162,553 patent/US7258861B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1105152A1 (en)	2001-06-13
AU764992B2 (en)	2003-09-04
CA2334941C (en)	2011-08-09
HUP0103117A3 (en)	2004-03-01
CZ2001538A3 (cs)	2001-08-15
JP4542266B2 (ja)	2010-09-08
TR200100338T2 (tr)	2001-12-21
PL345997A1 (en)	2002-01-14
CZ302862B6 (cs)	2011-12-21
ATE395072T1 (de)	2008-05-15
DE69937206D1 (de)	2007-11-08
WO2000009149A1 (en)	2000-02-24
AU5620999A (en)	2000-03-06
DE69937206T2 (de)	2008-06-19
DE69938743D1 (de)	2008-06-26
ATE374039T1 (de)	2007-10-15
US20030105021A1 (en)	2003-06-05
IL141064A0 (en)	2002-02-10
CN1181886C (zh)	2004-12-29
HUP0103117A2 (hu)	2001-12-28
HU227661B1 (hu)	2011-10-28
EP1264599B1 (en)	2007-09-26
CA2334941A1 (en)	2000-02-24
EP1247531A3 (en)	2002-12-18
US20030185791A1 (en)	2003-10-02
EP1264599A1 (en)	2002-12-11
NZ509604A (en)	2003-05-30
ZA200100656B (en)	2005-06-29
EP1247531A2 (en)	2002-10-09
US7258861B2 (en)	2007-08-21
IL141064A (en)	2009-09-01
PL203706B1 (pl)	2009-11-30
PT1264599E (pt)	2008-01-07
EP1247531B1 (en)	2008-05-14
HK1051805A1 (en)	2003-08-22
CN1312724A (zh)	2001-09-12
JP2002522508A (ja)	2002-07-23
ES2296872T3 (es)	2008-05-01
BR9912899A (pt)	2001-05-08

Publication	Publication Date	Title
DK1264599T3 (da)	2008-02-04	TNF-afledte peptider til anvendelse i behandling af ödem
EA200400632A1 (ru)	2004-10-28	Пептиды, эффективные в лечении опухолей и других заболеваний, требующих удаления или разрушения клеток
DK0397420T3 (da)	1995-08-21	Enzymatisk fjernelse af en aminoterminal proteinsekvens
EA199900778A1 (ru)	2000-04-24	ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И ИХ ИСПОЛЬЗОВАНИЕ ДЛЯ ИНГИБИРОВАНИЯ β-АМИЛОИДНОГО ПЕПТИДА
NO20012787L (no)	2001-08-06	GLP-1 analoger
CY1107668T1 (el)	2010-07-28	Χρηση αμινοξικων αντισπασμωδικων για τη θεραπευτικη αγωγη του πονου
DE69922819D1 (de)	2005-01-27	Methode zur prävention und behandlung von dehnungsstreifen (striae distensae) und deren verwendung in dermatologie
NO20012786D0 (no)	2001-06-06	Analoger av GLP-1
EA199900355A1 (ru)	2000-08-28	Теломераза обратная тринскриптаза
EA200201214A1 (ru)	2003-06-26	Замещенные тиоацетамиды
EP0873754A4 (en)	1999-03-24	AMINO ACID COMPOSITIONS
DE60217326D1 (de)	2007-02-15	Von neurofilamentproteinen abgeleitete peptide und deren medizinische verwendung
AR037778A1 (es)	2004-12-01	Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos
AR002742A1 (es)	1998-04-29	Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
DE69329899D1 (de)	2001-03-08	Behandlung von tropikalischer spastischer Paresis mit Peptide T
ATE342352T1 (de)	2006-11-15	Entwurf und verwendung von verbesserten zink- chelatbildenden peptiden zur regulation von matrix-metalloproteinasen
ATE272399T1 (de)	2004-08-15	Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz
DE69526972D1 (de)	2002-07-11	Verwendung von Gabapentin in der Behandlung vonAngst - und Panikstörungen
MXPA02012030A (es)	2004-08-19	Sustratos peptidicos de metalorpoteasas y metodos.
ATE281522T1 (de)	2004-11-15	Sentrin-spezifische menschliche protease senp1
DE50006409D1 (de)	2004-06-17	Injektionslösung enthaltend eine goldverbindung, calendula und belladonna extrakte zur behandlung von arthrosen
DE69812597D1 (de)	2003-04-30	Peptide zur Inhibition von HPV E7 Proteinen